/PRNewswire/ Scarlet Therapeutics ("Scarlet"), a leader in red blood cell-based therapeutics, announces today that it has raised seed funding from Science.
Scarlet Therapeutics, a leader in red blood cell-based therapeutics, has raised seed funding from Science Creates Ventures and Meltwind to develop its platform and build a pipeline of novel therapies.